Newgate Capital Management’s Allergan plc AGN Stock Holding History

Newgate Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$306K	Buy	+1,322	New	+$305K	0.25%	76

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Newgate Capital Management's AGN Position: Q2 2016 in Review

Newgate Capital Management opened a new position in Allergan plc (AGN) in Q2 2016: 1,322 shares worth $306K. The stake represents 0.25% of the portfolio and ranks #76 among its holdings.

1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Newgate Capital Management held 1,322 shares of Allergan plc worth $306K as of Q2 2016.
Allergan plc was a new Newgate Capital Management position in Q2 2016.
Allergan plc made up 0.25% of Newgate Capital Management's portfolio in Q2 2016, its #76 holding.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Newgate Capital Management's 13F filing for Q2 2016, filed 3 Aug 2016.